FDA Updates COVID-19 Jab Labels With ‘New Safety Information About Risks’ Of Heart Damage
10 Articles
10 Articles
FDA Issues Major Update on Risks from mRNA Vaccines · Caldron Pool
The U.S. Food and Drug Administration (FDA) has issued a significant update regarding the risks associated with myocarditis following mRNA COVID-19 vaccinations, particularly highlighting an increased risk among young men. The FDA’s new safety label, published on June 25, 2025, adds an updated warning for myocarditis linked to all mRNA vaccines. Dr. Vinay Prasad, Director of the FDA’s Center for Biologics Evaluation & Research, shared the detail…
The FDA Is Finally Adding Heart Risk Info to COVID Vaccines.
PULSE POINTSWHAT HAPPENED: The U.S. Food and Drug Administration (FDA) updated the warning labels on Pfizer and Moderna’s COVID-19 mRNA vaccines to include new information regarding the risks of myocarditis and pericarditis, particularly in young males.WHO WAS INVOLVED: The FDA, Pfizer, Moderna, and study participants, including young males affected by myocarditis.WHEN & WHERE: The updated safety communication was issued on June 25, 2024, in the…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
To view factuality data please Upgrade to Premium